MedPath

The Effects of Platelet-Rich Plasma (PRP) during cesarean section on the integrity and thickness of uterine scar.

Not Applicable
Recruiting
Conditions
Cesarean section surgery.
Delivery by caesarean section, unspecified
Registration Number
IRCT20190108042291N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
80
Inclusion Criteria

Emergency and non-emergency cesarean section for the first time

Exclusion Criteria

Presence of uterine anomalies with or without previous repair
Presence of uterine myoma at the site of caesarean incision
History of myomectomy at site of caesarean incision
Presence of placenta previa and placenta accrete
Prolonged rupture of membranes without chorioamnionitis criteria (consist of fever, uterine tenderness…)
Rupture of membranes with chorioamnionitis criteria (consist of fever, uterine tenderness…)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
terine closure time. Timepoint: During the surgery. Method of measurement: Chronometer.;Primary postpartum hemorrhage. Timepoint: During and the day after surgery. Method of measurement: Complete Blood Count(CBC).;Pain. Timepoint: The day, week and month after surgery. Method of measurement: VAS scale.;Infection rate. Timepoint: The day, week and month after surgery. Method of measurement: Thermometer.
Secondary Outcome Measures
NameTimeMethod
Residual myometrial thickness. Timepoint: 3 months after the surgery. Method of measurement: Ultrasound examination will be performed 3 months after the operation to assess the integrity of scar by measuring the residual myometrial thickness and the depth of the possible scar defect.;The depth of cesarean section scar defect(thickness). Timepoint: 3 months after the surgery. Method of measurement: Ultrasound examination will be performed 3 months after the operation to assess the integrity of scar by measuring the residual myometrial thickness and the depth of the possible scar defect.
© Copyright 2025. All Rights Reserved by MedPath